Vianex

PHARMACEUTICAL COMPANY Member of the Giannakopoulos Group

Certification - QA/QC

Quality Assurance QA-Quality Control QC - Compliance

Product quality

Quality Assurance is ensured by the Group’s central Quality Assurance & Quality Management Department and by four individual QA departments, one in each separate production plant.

Quality control (QC) is carried out by four laboratories, one in each separate production plant, which combine the most modern facilities with state of the art analytical instruments.

120 experienced and highly-qualified scientists (chemists, pharmacists, biologists, biochemists and doctors) work in the QA and QC Departments to ensure that our products are of high quality and remain safe for public health.

Each year, 20 large multinational firms inspect VIANEX facilities to certify that the quality system complies with modern international standards. These firms then approve the circulation of pharmaceutical products for Greek and international markets.

Quality Standards for Distribution Services

Our distribution and product storage services comply with European GDPs.

Two specialised units, one in each distribution center, are staffed by pharmacists, who inspect the quality of products in distribution, transport and delivery to the customer.

The cold chain system protects sensitive products (e.g. vaccines, biotechnology products), in order to ensure that quality does not suffer given the special storage requirements.

Quality Services for Scientific Information - FCPA Compliance

Medical information services are subject to a strict supervisory system, implemented in Greek pharmaceutical companies for the first time in 2000.

The three compliance control departments and the medical units, one for each pharmaceutical sector, are staffed by 20 scientists (doctors, pharmacists, biologists and chemists).

The specialised pharmacovigilance staff follow European pharmacovigilance regulations and ensure that our products are safe.

All promotional materials (e.g. brochures or presentations) are checked prior to release in accordance with the approved details of each product.

All presentations etc. at events/conferences are evaluated and conducted in accordance with the stringent requirements of the EOF.

All exchanges with health professionals are fully transparent, in accordance with the legal requirements of the industry, the Code of Ethics and international FCPA regulations.